On September 3, 2020 CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, reported that its Chief Executive Officer, Steven Engle, will present a company update at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020 (Press release, CohBar, SEP 3, 2020, View Source [SID1234564419]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Annual Global Investment Conference
Tuesday, September 15 at 4:00 PM ET
Webcast: The presentation may be accessed via webcast at the scheduled time, or following the presentation, using the following link: View Source